Latest News and Press Releases

Following the changes to the Executive Leadership Team, announced on 19.08.2025*, we are pleased to share with you the updated presenters list for our Capital Markets Day on 2 September 2025. For...

2024/25 Delårsrapport, 9M 2024/25 1. oktober 2024 - 30. juni 2025 Coloplast leverede en organisk vækst på 7% og en overskudsgrad1 på 28% i 3. kvartal. Den rapporterede omsætning i danske kroner...

2024/25 Interim financial results, 9M 2024/25 1 October 2024 - 30 June 2025 Coloplast delivered organic growth of 7% and an EBIT margin1 of 28% in Q3. Reported revenue in DKK grew 1% with negative...

Coloplast ændrer i ledelsesteamet  Coloplasts bestyrelse laver ændringer til ledelsesteamet (ELT) for at understøtte en succesfuld eksekvering af ny strategi. I løbet af de seneste måneder har...

Coloplast announces changes to Executive Leadership Team The Coloplast Board of Directors are making changes to the Executive Leadership Team (ELT) to support the successful execution of the new...

Tuesday, 19 August 2025 at 11.00 - 12.00h CESTIn connection with the publication of Coloplast’s interim financial results for 9M 2024/25, to be released same day in the morning around 07.30h CEST,...

The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)Ellehammersvej 20, 2770 Kastrupfrom 10.30 - 17.00 CEST(Central European Summer Time) Coloplast invites...

Se venligst vedlagte pdf.   Vedhæftet fil 08052025_handel_med_aktier_GL ...

Please see enclosed pdf.   Attachment 08052025_trading_in_shares_GL ...

Interim financial results, H1 2024/25 1 October 2024 - 31 March 2025 Coloplast delivered 6% organic growth in Q2, impacted by the product recall in Interventional Urology and a softer quarter in...